Current evidence does not indicate significant risk with montelukast during pregnancy, but safety data is less extensive than for inhaled therapies. For women whose asthma is well controlled on montelukast and cannot be adequately managed with inhalers alone, continuing it under specialist supervision may be appropriate. This decision should always be made in consultation with Dr. Dixit Kumar Thakur at Pulmovista Clinics rather than independently.